Pharma Moves

A screenshot of Novartis's data42 initiative, shown during the company's HLTH presentation on digital strategy.
By Jonah Comstock 03:40 pm October 15, 2020
Novartis's digital strategy hasn't changed too much since MobiHealthNews spoke with the pharma company in 2018. But, at the HLTH virtual conference this week, Novartis Chief Digital Officer Betrand Bodson reiterated the company's four-part strategy, focusing especially on its partnerships, including those with Microsoft, Amazon and China's Tencent. "We started this agenda in earnest two and a...

Credit: Abbott

By Tammy Lovell 08:05 am September 21, 2020
Abbott announced that its Libre Sense Glucose Sport Biosensor has achieved a CE Mark, paving the way for a European roll-out.   The Libre Sense biosensor provides continuous glucose monitoring (CGM) to help athletes understand the efficacy of their nutrition choices on training and competition. Based on Abbott's FreeStyle Libre technology for people living with diabetes, it is the first personal-...
By Laura Lovett 11:19 am August 28, 2020
It’s no secret that digital is shaping what clinical trials will look like in the future. A recently published position paper published in Nature discusses the potentials and challenges of digital clinical trials. The paper builds on a workshop held by the U.S. National Institutes of Health and the National Science Foundation in April of 2019.  One of the big opportunities that the paper outlines...
By Dave Muoio 01:10 pm August 19, 2020
The United States Postal Service has been at the heart of a bitter partisan divide over the last few months of COVID-19 and the U.S. election season. Prominent Democratic politicians have alleged that recent reforms and administrative changes ushered by recently appointed Postmaster General Louis DeJoy have led to widespread service delays across the country. At the same time, President Donald...
By Laura Lovett 03:06 pm August 11, 2020
This morning artificial intelligence-based drug discovery platform Atomwise scored a whopping $123 million in Series B funding led by B Capital Group and Sanabil Investments. DCVC, BV, Tencent, Y Combinator, Dolby Family Venture and AME Cloud Ventures also participated in the funding round.  WHAT IT DOES The company uses artificial intelligence, specifically “convolution neural networks,” in...
By Laura Lovett 01:40 pm August 4, 2020
Cardio-focused digital health company Eko has inked a deal with AstraZeneca in order for the two to work together to develop digital health-screening tools.  According to the companies, the pharm giant will be looking to employ Eko’s AI-enabled algorithms in developing early detection tools, as well as to use the tech in clinical trials.  WHY IT MATTERS  Heart disease accounts for roughly one in...
By Laura Lovett 02:57 pm July 16, 2020
Pharma giant Roche and its subsidiary Genentech have inked a deal with PicnicHealth, a startup that helps patients access and share their medical records.  The real-world evidence deal will allow the pharmaceutical companies to have access to PicnicHealth’s set of de-identified patient records in order to gain insights about certain diseases and treatments. Patients must first consent to their...
By Dave Muoio 02:14 pm July 16, 2020
Jerusalem-based Teva Pharmaceuticals announced this week the U.S. launch of its ProAir Digihaler. The sensor-laden albuterol dispenser requires a prescription, and is indicated for those aged four years or older with reversible obstructive airway diseases such as asthma and COPD, as well as for the prevention of exercise-induced bronchospasm (EIB) among this same group. The device connects to a...
By Mallory Hackett 03:30 pm July 15, 2020
Tabula Rasa HealthCare today launched MedWise on its PrescribeWellness platform for pharmacists to cumulatively compare how different medications interact with each other.  The company, which focuses on improving medication safety, developed this service to allow pharmacists to see how medications will work together on a larger scale than one-to-one. By doing this, Tabula Rasa says adverse drug...
By Laura Lovett 02:10 pm July 9, 2020
Pharma giant Otsuka is rolling out a new kidney focused platform called NephU that provides online resources about nephrology conditions and a place for clinicians to collaborate and share information amongst themselves, and with patients.  Users will be able to tap into an online library of resources that include video, audio, webinars and podcasts. According to the site, the “community”...